Skip to content

Uric Acid Pap

by Boehringer Mannheim Corp. 510(k) 2 variants

Active United States

510(k) K873363

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK873363 Date19 Oct 1987ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

1 recall · FDA

    • Terminated Z-1931-2015 FDA Class II initiated 7 May 2015

    Possible drug interference when using the Trinder reaction method on multiple Cobas Analyzers. Results of Trinder tests may be falsely decreased when the tests are run with urine samples (Creatinine plus and Uric Acid applications only) or blood samples collected before sufficient time has lapsed after the administration of the drugs Acetaminophen and N-acetylcysteine.

Specification

510(k)

510(k) Number
FDA Product Code
KNK
Device Class
Class I
Regulation
21 CFR Part 862.1775
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Other devices from Boehringer Mannheim Corp.

See all devices from Boehringer Mannheim Corp. →